EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of Cell-Free DNA in Relapsed Head and Neck Cancer

Annie Kanchan Baa, Atul Sharma, Mayank Singh, Ashna Gupta, Ahitagni Biswas, Sacchidanand Jee Bharti, Alok Thakar, Rajeev Kumar, Raja Pramanik

Indian Journal of Medical and Paediatric Oncology · 01.02.2025 · 46 (01) · 087-092

DOI: 10.1055/s-0044-1792008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Medical and Paediatric Oncology, erschienen am 01.02.2025. Verfasst von Annie Kanchan Baa und 8 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Owing to the aggressive biology of head and neck squamous cell carcinoma (HNSCC), new biomarkers that can facilitate the diagnosis and tracking of tumour growth are the need of the hour. Liquid biopsy has emerged as an easier tool than tissue biopsy to monitor the emergence of treatment resistance or the recurrence of disease at the molecular level.

Objectives

To assess the role of cell-free DNA (cfDNA) as a biomarker for relapsed HNSCC. Materials and Methods This study is a Phase 2 interventional study (NCT: CTRI/2020/02/023378) that assessed the response rates of a new triplet drug regimen in refractory or relapsed HNSCC. Thirty-five patients underwent blood sampling before the commencement of therapy and at 3 months of treatment. Isolation of cfDNA was done using magnetic beads (molecular weight near 170 kb) for quantification.

Results

Twenty-eight patients had comparable data at baseline and after 3 months of treatment. The mean cfDNA reading at baseline was 8.9 ng/μL (range: 2.6 -7.3 ng/μL) of blood. The cfDNA concordance with clinical and radiological outcomes was 54.2%. The patients who responded to therapy were compared over time with patients who did not respond. Repeated measures testing found a significant difference (p 1?4 0.0035) in changes to the cfDNA levels of these two groups.

Conclusion

This study posits the potential value of liquid biopsy in the treatment of recurrent HNSCC. Our findings prove the clinical relevance as well as limitations of cfDNA, which warrant extrapolation in an upfront setting too.

Zitieren

APA

Baa, A. K., Sharma, A., Singh, M., Gupta, A., Biswas, A., Bharti, S. J., Thakar, A., Kumar, R., & Pramanik, R. (2025). Role of Cell-Free DNA in Relapsed Head and Neck Cancer. Indian Journal of Medical and Paediatric Oncology, 46(01), 087-092. https://doi.org/10.1055/s-0044-1792008

Vancouver

Baa AK, Sharma A, Singh M, Gupta A, Biswas A, Bharti SJ, et al. Role of Cell-Free DNA in Relapsed Head and Neck Cancer. Indian Journal of Medical and Paediatric Oncology. 2025;46(01):087-092. doi:10.1055/s-0044-1792008

BibTeX
@article{Baa2025,
  author = {Baa, Annie Kanchan and Sharma, Atul and Singh, Mayank and Gupta, Ashna and Biswas, Ahitagni and Bharti, Sacchidanand Jee and Thakar, Alok and Kumar, Rajeev and Pramanik, Raja},
  title = {Role of Cell-Free DNA in Relapsed Head and Neck Cancer},
  journal = {Indian Journal of Medical and Paediatric Oncology},
  year = {2025},
  volume = {46},
  number = {01},
  pages = {087--092},
  doi = {10.1055/s-0044-1792008}
}
Kostenlos starten →